3-(3-pyrrolinomethyl)-4'-thiomethylbenzophenone, 97.0%, 1g

2-(2-aminoethyl)-4,6-pyrimidinediol hydrochloride hydrate, 95.0%, 250mg

(2S,3R)-5-bromo-3-(3,5-dimethoxyphenyl)-2-(4-methoxyphenyl)-2,3-dihydro-1-benzofuran, 95+%, 500mg

2,6-Difluoronitrobenzene>98.0%(GC)5g

4-Méthyl-3-nitroaniline, min.99%, pour la synthèse, 50 g, emballage en verre

Bis(4-fluorophenyl)sulfone, 98.0%, 1g

Ethyl 2-(4'-bromophenyl)-1,3-oxazole-4-carboxylate, 95.0%, 250mg

6-Methylsalicylaldehyde, 95.0%, 1g

5,7-Dibromoimidazo[1,5-a]pyridine, 98%, 1g

2,5-Dichloro-4-methyl-6-(methylthio)nicotinonitrile, 95%, 100mg

2,4-Dihydroxybenzoic acid, 95.0%, 100g

14-AMINO-N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)-3,6,9,12-TETRAOXATETRADECANAMIDE HYDROCHLORIDE, 95%, 100mg

(4S,4'S)-4,4'-Di((S)-sec-butyl)-4,4',5,5'-tetrahydro-2,2'-bioxazole, 97%, 1g